Molecular Partners AG reported earnings results for the full year ended December 31, 2022. For the full year, the company reported revenue was CHF 189.6 million compared to CHF 9.75 million a year ago. Net income was CHF 117.85 million compared to net loss of CHF 63.79 million a year ago.

Basic earnings per share from continuing operations was CHF 3.63 compared to basic loss per share from continuing operations of CHF 2.06 a year ago. Diluted earnings per share from continuing operations was CHF 3.54 compared to diluted loss per share from continuing operations of CHF 2.06 a year ago.